Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients

Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients

Abstract Background Neoadjuvant radiotherapy (RT) has been shown to improve local control; however, whether it can improve overall survival (OS) in locally advanced rectal cancer (LARC) patients remains controversial. We therefore aimed to examine the benefits of surgery alone, neoadjuvant radiother...

Full description

Bibliographic Details
Main Authors: Feng Zhao, Jili Wang, Hao Yu, Xiaofei Cheng, Xinke Li, Xuan Zhu, Xiangming Xu, Jianjiang Lin, Xin Chen, Senxiang Yan
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Radiation Oncology
Subjects:
Rectal cancer
Radiotherapy (RT)
Surgery
Chemotherapy
Overall survival (OS)
Online Access:http://link.springer.com/article/10.1186/s13014-020-01497-4

Internet

http://link.springer.com/article/10.1186/s13014-020-01497-4

Similar Items